Tacke F - Search Results

1

Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients.

Koch A, Sanson E, Voigt S, Helm A, Trautwein C, Tacke F. Koch A, et al. Among authors: tacke f. J Crit Care. 2011 Apr;26(2):166-74. doi: 10.1016/j.jcrc.2010.07.015. J Crit Care. 2011. PMID: 20869198

2

High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo.

Tacke F, Wüstefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP, Trautwein C, Brabant G. Tacke F, et al. J Hepatol. 2005 May;42(5):666-73. doi: 10.1016/j.jhep.2004.12.024. J Hepatol. 2005. PMID: 15826715

3

Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis.

Yagmur E, Tacke F, Weiss C, Lahme B, Manns MP, Kiefer P, Trautwein C, Gressner AM. Yagmur E, et al. Among authors: tacke f. Clin Biochem. 2006 Jan;39(1):39-45. doi: 10.1016/j.clinbiochem.2005.07.016. Clin Biochem. 2006. PMID: 16321365

4

Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases.

Yagmur E, Trautwein C, Gressner AM, Tacke F. Yagmur E, et al. Among authors: tacke f. Am J Gastroenterol. 2006 Jun;101(6):1244-52. doi: 10.1111/j.1572-0241.2006.00543.x. Am J Gastroenterol. 2006. PMID: 16771945

5

Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4.

Yagmur E, Weiskirchen R, Gressner AM, Trautwein C, Tacke F. Yagmur E, et al. Among authors: tacke f. Diabetes Care. 2007 May;30(5):1168-72. doi: 10.2337/dc06-2323. Epub 2007 Mar 2. Diabetes Care. 2007. PMID: 17337499

6

A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease.

Tacke F, Fiedler K, Trautwein C. Tacke F, et al. Scand J Gastroenterol. 2007 Mar;42(3):374-82. doi: 10.1080/00365520600930826. Scand J Gastroenterol. 2007. PMID: 17354118

7

Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.

Tacke F, Gäbele E, Bataille F, Schwabe RF, Hellerbrand C, Klebl F, Straub RH, Luedde T, Manns MP, Trautwein C, Brenner DA, Schölmerich J, Schnabl B. Tacke F, et al. Dig Dis Sci. 2007 Dec;52(12):3404-15. doi: 10.1007/s10620-007-9758-8. Epub 2007 Apr 6. Dig Dis Sci. 2007. PMID: 17415633

8

Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course.

Tacke F, Trautwein C, Yagmur E, Hellerbrand C, Wiest R, Brenner DA, Schnabl B. Tacke F, et al. J Gastroenterol Hepatol. 2007 Aug;22(8):1256-64. doi: 10.1111/j.1440-1746.2006.04621.x. J Gastroenterol Hepatol. 2007. PMID: 17688666

9

High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin.

Gressner OA, Koch A, Sanson E, Trautwein C, Tacke F. Gressner OA, et al. Among authors: tacke f. Clin Biochem. 2008 Aug;41(12):974-80. doi: 10.1016/j.clinbiochem.2008.05.005. Epub 2008 May 27. Clin Biochem. 2008. PMID: 18538666

10

Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis.

Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, Janetzko A, Wiederholt T, Berg T, Müller T, Trautwein C, Gressner AM, Weiskirchen R. Kovalenko E, et al. Among authors: tacke f. J Viral Hepat. 2009 Sep;16(9):612-20. doi: 10.1111/j.1365-2893.2009.01110.x. Epub 2009 Feb 20. J Viral Hepat. 2009. PMID: 19243500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results